Mergers & Acquisitions
Executives say the deal will give ProMedica a platform for managing the silver tsunami of baby boomer patients by eradicating traditional barriers of where care gets delivered.
MSD has continued to strengthen its leadership in the home infusion space while also significantly expanding its presence across the broader post-acute landscape.
Spokesperson says the details are still being worked out about physical locations or shared access to care services and they hope to finalize the arrangement this year.
The move comes during a prolonged period of financial struggle for CHS, which has seen diminished cash flow and admissions, and a big hit from bad debt.
Key stakeholders had a hearing in front of the Public Health Council earlier this month where councilors voted unanimously to approve the deal.
Companies say the cross-sector partnership will create open source platform that it hopes other tech companies will use to innovate.
Bipartisan bill is expected after questions are answered by April 26 deadline; Senate HELP committee gets ready to markup Opioid Crisis Response Act.
The deal was first announced last month. Financial terms were not disclosed.
Biopharmaceuticals garnered about half of the funding so far this year.
A look at the latest facilities building and modernization projects just getting underway.